Facebook Pixel Code

Senores Pharmaceuticals Share Price

NSE
BSE

SENORES PHARMACEUTICALS

Smallcap | BSE

Here's the live share price of Senores Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,485.00 Closed
-0.39₹ -5.75
As on Aug 13, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Senores Pharmaceuticals Price Performance

Today's LowToday's High
₹1,471.50₹1,510.70
₹1,485.00
52 Weeks' Low52 Weeks' High
₹641.25₹1,509.20
₹1,485.00
Open Price
₹1,494.40
Prev. Close
₹1,490.75
Volume
8,824

Source: Dion Global

Senores Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Senores Pharmaceuticals
11.783.5751.9889.11118.1338.6021.63
Sun Pharmaceutical Industries
-0.060.986.4914.4118.5019.6320.09
Divi's Laboratories
2.5122.6025.1437.7839.2731.5811.42
Torrent Pharmaceuticals
-1.79-1.4513.5319.6934.7835.2626.89
Zydus Lifesciences
6.033.7124.9329.6318.6022.2816.00
Cipla
-0.952.4010.099.78-6.465.7610.31
Lupin
-5.46-9.482.062.8113.6627.8618.28
Dr. Reddy's Laboratories
2.64-2.32-4.67-4.86-3.721.195.31
Mankind Pharma
-0.53-3.640.4417.36-1.939.9711.17
Laurus Labs
0.2818.2043.7982.26113.2268.5321.09
Aurobindo Pharma
4.226.9010.6244.2453.7923.8616.83
Biocon
-4.911.33-0.4210.1115.4917.792.30
Alkem Laboratories
-3.38-2.80-0.660.320.5212.648.15
Glenmark Pharmaceuticals
-0.21-0.310.7014.9112.9242.2232.43
Abbott India
-0.930.881.344.37-16.255.387.77
Anthem Biosciences
5.8816.957.9326.8915.816.173.66
Gland Pharma
12.7019.9059.9365.7651.2622.56-7.20
Ipca Laboratories
3.53-1.6119.0820.5631.5626.638.58
Ajanta Pharma
4.155.6215.8123.8835.5227.9019.28
GlaxoSmithKline Pharmaceuticals
2.499.379.841.92-4.6823.1410.45

Source: Dion Global

Over the last one year, Senores Pharmaceuticals has gained 118.13% compared to peers like Sun Pharmaceutical Industries (18.50%), Divi's Laboratories (39.27%), Torrent Pharmaceuticals (34.78%). From a 5 year perspective, Senores Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (20.09%) and Divi's Laboratories (11.42%).

Senores Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Senores Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
51,378.51,402.11
101,352.181,379.4
201,377.911,367.9
501,309.511,294.39
1001,106.721,165.1
200949.881,004.36

Source: Dion Global

Senores Pharmaceuticals Share Holding Pattern

In the latest quarter, Senores Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 9.77%, FII holding rose to 6.62%, and public shareholding moved down to 37.78% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Senores Pharmaceuticals Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
6,08,7720.4580.96
4,70,6300.4262.59
4,33,6632.0957.67
90,0001.3211.97

Source: Dion Global

* Excluding Index & Arbitrage Funds

Senores Pharmaceuticals Corporate Actions

Date Time
Announcement
Aug 04, 2026, 11:22 PM IST ISTSenores Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Aug 04, 2026, 11:19 PM IST ISTSenores Pharma. - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Aug 03, 2026, 08:48 PM IST ISTSenores Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jul 28, 2026, 12:57 AM IST ISTSenores Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jul 27, 2026, 11:23 PM IST ISTSenores Pharma. - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue

Source: Dion Global

About Senores Pharmaceuticals

Senores Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 26/12/2017 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24290GJ2017PLC100263 and registration number is 100263. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 106.09 Cr. and Equity Capital is Rs. 46.05 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Mr. Sanjay Shaileshbhai Majmudar
    Chairman, Non Ind & Non Exe Director
  • Mr. Swapnil Jatinbhai Shah
    Managing Director
  • Mr. Chetan Bipinchandra Shah
    Whole Time Director & COO
  • Mr. Deval Rajnikant Shah
    WholeTime Director & CFO
  • Mr. Hemanshu Nitinchandra Pandya
    Non Exe.Non Ind.Director
  • Mr. Jitendra Babulal Sanghvi
    Non Exe.Non Ind.Director
  • Mr. Ashokkumar Vijaysinh Barot
    Non Exe.Non Ind.Director
  • Mr. Arpit Deepakkumar Shah
    Non Exe.Non Ind.Director
  • Mr. Kalpit Rajesh Gandhi
    Ind. Non-Executive Director
  • Mr. Udayan Dileep Choksi
    Ind. Non-Executive Director
  • Mrs. Manjula Devi Shroff
    Ind. Non-Executive Director
  • Mr. Naresh Bansilal Shah
    Ind. Non-Executive Director

FAQs on Senores Pharmaceuticals Share Price

What is the share price of Senores Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Senores Pharmaceuticals is ₹1,485.00 as on Aug 13, 2026.

What kind of stock is Senores Pharmaceuticals?

The Senores Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Senores Pharmaceuticals?

The market cap of Senores Pharmaceuticals is ₹6,838.96 Cr as on Aug 13, 2026.

What are today's High and Low prices of Senores Pharmaceuticals?

Today’s highest and lowest price of Senores Pharmaceuticals are ₹1,510.70 and ₹1,471.50.

What are the 52 Week High and 52 Week Low of Senores Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Senores Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Senores Pharmaceuticals is ₹1,509.20 and 52-week low of Senores Pharmaceuticals is ₹641.25 as on Aug 13, 2026.

How has the Senores Pharmaceuticals performed historically in terms of returns?

The Senores Pharmaceuticals has shown returns of -0.39% over the past day, 3.57% for the past month, 51.98% over 3 months, 118.13% over 1 year, 38.6% across 3 years, and 21.63% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Senores Pharmaceuticals?

P/E ratio of and PB ratio of Senores Pharmaceuticals are 54.12 and 7.33 on Aug 13, 2026. While the company gives a dividend yield of 0.00 per annum.

Source: Dion Global